Multivariate analysis further confirmed that high GROβ cytoplasmic staining and small mitotic index independently predicted poor prognosis in GIST patients (for 10-year and 5-year overall survival, resp). This evidence concerns the gene CXCL2 and gastrointestinal stromal tumor.